Litcius/Paper detail

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments

Joel M. Gelfand, April W. Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna D. Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo Re, George M. Martin, Joseph F. Merola, José U. Scher, Sergio Schwartzman, James R. Treat, Abby S. Van Voorhees, Christoph T. Ellebrecht, Justine Fenner, Anthony J. Ocon, Maha N. Syed, Erica J. Weinstein, George Gondo, Sue Heydon, Samantha Koons, Christopher T. Ritchlin

2021Journal of the American Academy of Dermatology98 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)PsoriasisPandemicDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakTask forceVirologyDermatologyPathologyInfectious disease (medical specialty)OutbreakPublic administrationPolitical sciencePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsCOVID-19 and healthcare impacts